Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 13,192
  • Shares Outstanding, K 97,718
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,458 K
  • 60-Month Beta 3.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.84
Trade BIOV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.090 +50.00%
on 05/12/22
0.150 -10.00%
on 04/25/22
-0.005 (-3.57%)
since 04/20/22
3-Month
0.090 +50.00%
on 05/12/22
0.185 -27.03%
on 02/28/22
-0.040 (-22.86%)
since 02/18/22
52-Week
0.090 +50.00%
on 05/12/22
0.650 -79.23%
on 09/20/21
-0.105 (-43.75%)
since 05/20/21

Most Recent Stories

More News
Stocks in play: BioVaxys Technology Corp

Announced today that Hospices Civils de Lyon, France has agreed to serve as a clinical study site for ...

BIOV.CN : 0.135 (+3.85%)
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression

Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past...

BIOV.CN : 0.135 (+3.85%)
BVAXF : 0.1000 (+5.60%)
CLSN : 2.36 (+0.85%)
IMGN : 3.58 (+1.42%)
ZNTL : 22.41 (-5.60%)
BMY : 76.19 (+0.30%)
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement

Vancouver, BC –  May 18, 2022 — BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or “Company”), announced today that Hospices Civils de Lyon, France (“HCL”)...

BVAXF : 0.1000 (+5.60%)
BIOV.CN : 0.135 (+3.85%)
Stocks in play: BioVaxys Technology Corp

Announced today that it has continued to expand the patent coverage for its cancer vaccine platform ...

BIOV.CN : 0.135 (+3.85%)
Stocks in play: BioVaxys Technology Corp

Announces that Mr. Anthony Dutton has been appointed as a director of the Company. Anthony is currently ...

BIOV.CN : 0.135 (+3.85%)
Stocks in play: BioVaxys Technology Corp

Announced today that it has entered into an agreement with the Deaconess Research Institute to supply ...

BIOV.CN : 0.135 (+3.85%)
Advanced Immunological and Clinical Trials for Treating Ovarian Cancer Accelerating

Palm Beach, FL – April 25, 2022 – FinancialNewsMedia.com News Commentary – The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer...

BIOV.CN : 0.135 (+3.85%)
BVAXF : 0.1000 (+5.60%)
CTIC : 4.69 (-3.70%)
IMGN : 3.58 (+1.42%)
CLVS : 0.7130 (-0.04%)
SBFM : 1.7300 (-4.95%)
The Power Play by The Market Herald Releases Interviews With Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp.

VANCOUVER, BC / ACCESSWIRE / March 30, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton...

GBAR.TO : 0.50 (-3.85%)
VOX.VN : 3.000 (unch)
TOC.CN : 0.750 (unch)
GTTX.CN : 0.320 (unch)
PMC.CN : 0.050 (unch)
SWIM.CN : 0.100 (unch)
BIOV.CN : 0.135 (+3.85%)
Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2022 – USA News Group  –  Whenever a new COVID-19 variant emergences, health authorities have had limited options...

BIOV.CN : 0.135 (+3.85%)
BVAXF : 0.1000 (+5.60%)
SRNE : 1.5900 (+0.63%)
PFE : 52.47 (+3.59%)
BNTX : 163.00 (-2.90%)
MRNA : 136.25 (-4.97%)
Ineffectiveness Against Omicron Driving Development of Universal and Variant-Proof Vaccines

Biotech Insider – Despite early reports of a ‘ significant increase ’ in protection from mRNA against Omicron, calls for an Omicron-specific are ramping up, while there’s even more demand for a...

BIOV.CN : 0.135 (+3.85%)
BVAXF : 0.1000 (+5.60%)
GSK : 44.52 (+2.20%)
SNY : 54.40 (+2.53%)
NVAX : 53.42 (-8.57%)
AZN : 66.21 (+2.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.143
2nd Resistance Point 0.142
1st Resistance Point 0.138
Last Price 0.135
1st Support Level 0.133
2nd Support Level 0.132
3rd Support Level 0.128

See More

52-Week High 0.650
Fibonacci 61.8% 0.436
Fibonacci 50% 0.370
Fibonacci 38.2% 0.304
Last Price 0.135
52-Week Low 0.090

See More

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar